Latest News and Press Releases
Want to stay updated on the latest news?
-
Tallinn, Estonia, 2011-02-10 06:59 CET (GLOBE NEWSWIRE) -- Nordecon reports its unaudited preliminary results for Q4 and 12M of the year ended 31 December 2010. The full unaudited interim report for...
-
Orkla's operating profit (EBITA) increased by 14% from NOK 1,161 million in the fourth quarter of 2009 to NOK 1,322 million in the same period of 2010. Full-year operating profit (EBITA) increased by...
-
HONG KONG--(Marketwire - February 10, 2011) - Travelzoo Asia Pacific, a licensee of global Internet media company Travelzoo Inc. (NASDAQ: TZOO), released its latest findings...
-
TOKYO, Feb. 10, 2011 (GLOBE NEWSWIRE) -- Internet Initiative Japan Inc. ("IIJ") (Nasdaq:IIJI) (TSE1:3774), one of Japan's leading Internet-access and comprehensive network solutions providers, today...
-
TOKYO, Feb. 10, 2011 (GLOBE NEWSWIRE) -- Internet Initiative Japan Inc. ("IIJ") (Nasdaq:IIJI) (TSE:3774) today announced its consolidated financial results for the nine months ended December 31,...
-
MACOMB TOWNSHIP, MI and LAKE ORION, MI--(Marketwire - February 9, 2011) - Hampson Aerospace Tooling Solutions, a division of Hampson Industries PLC, an international aerospace, tooling and automation...
-
DALLAS, Feb. 9, 2011 (GLOBE NEWSWIRE) -- Archipelago Learning Inc. (Nasdaq:ARCL), a leading software-as-a-service (SaaS) provider of education solutions, plans to report the Company's fourth quarter...
-
ATLANTA, Feb. 9, 2011 (GLOBE NEWSWIRE) -- On February 2, 2011, a Financial Industry Regulatory Authority (FINRA) arbitration panel awarded damages and assessed costs against Regions Financial Corp.'s...
-
Prospect Capital Reports Operating Results of 38 Cents per Share for Quarter Ended December 31, 2010
NEW YORK, NY--(Marketwire - February 9, 2011) - Prospect Capital Corporation (NASDAQ: PSEC) ("Company" or "Prospect") today announced financial results for our second quarter ended December 31,...
-
AURORA, ON--(Marketwire - February 9, 2011) - Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a developer of biopharmaceutical drug candidates for the prevention and treatment of...